NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Medical Devices · USD

Hyperfine, Inc. (HYPR) Stock Analysis

Hyperfine, Inc. (HYPR) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

HYPR

$0.81

−$0.02 (−2.87%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare HYPR with… →

HYPR Key Statistics

As of Sep 4, 2026
Trading
Open
$0.82
Previous Close
$0.84
Day's Range
0.80–0.83
52-Week Range
0.79–2.22
Volume
524.50K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.41
Valuation
Market Cap
$86.25M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
5.22
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.37
Financials (FY)
Revenue (FY)
$13.56M+5.22%
Net Income (FY)
−$35.57M
Profit marginThe share of revenue left as profit after all costs and taxes.
−210.75%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
90.99M
1-Year Return
−27.41%
Dividend and dates
Earnings Date
November 12, 2026
Avg Volume
985.60K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

HYPR Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−16.96%
2025+11.25%
2024−21.43%
2023+33.33%
2022−88.41%
2021−28.85%

As of September 4, 2026.

HYPR Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$13.56M−$35.57M−262.3%
2024$12.89M−$40.72M−315.9%
2023$11.03M−$44.24M−401.0%
2022$6.81M−$73.16M−1073.7%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$13.56M$6.75M−$37.09M−$35.57M−262.3%
2024$12.89M$5.89M−$43.22M−$40.72M−315.9%
2023$11.03M$4.76M−$48.12M−$44.24M−401.0%
2022$6.81M$907.00K−$73.87M−$73.16M−1073.7%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

HYPR Valuation vs Medical Devices Median

Median of 151 stocks
MetricHYPRMedical Devices medianvs median
P/S ratio5.222.9875% above
Profit margin−210.75%−1.69%209.1 pts below

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 13 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Hyperfine, Inc. (HYPR) at $86.25M. The company sits in the Healthcare sector, in the Medical Devices industry. Headcount on file is 102.

The 52-week range on file runs from $0.79 to $2.22. HYPR last closed at $0.81 on September 4, 2026. That is −$0.02 (−2.87%) against the previous close. The latest close sits 2.65% above that 52-week low.

Financial Health

In fiscal 2025, Hyperfine, Inc. reported revenue of $13.56M. Against the prior fiscal year total of $12.89M, that is a change of +5.22%. The same year closed with a net loss of $35.57M. The reported profit margin is −210.75%. That is 209.1 percentage points below the Medical Devices median of −1.69%. Trailing earnings per share are −0.37.

Across the 4 fiscal years on file, revenue moves from $6.81M in 2022 to $13.56M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. Measured against sales, the shares trade at 5.22 times revenue. On price-to-sales that is 75.25% above the Medical Devices median of 2.98. 151 Medical Devices companies report these metrics, and the medians quoted come from that group.

The reported beta is 1.41. Annualized volatility over the trailing 5 years is 97.54%. The trailing one-year price return is −27.41%. Measured over 5 years, that is −39.30% a year compounded.

Growth & Income

The record shows no dividend for HYPR.

So far in 2026 the price is −16.96%. Across the complete calendar years on file, 2023 returned +33.33% and 2022 returned −88.41%. Of the 5 complete calendar years on file, 2 finished higher.

Peer Comparison

Hyperfine, Inc. (HYPR) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Hyperfine, Inc. HYPR $86.25M —
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. Hyperfine, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

 MDT

Medtronic plc.

$120.46B

 SYK

Stryker Corporation

$116.27B

 BSX

Boston Scientific Corporation

$69.27B

 EW

Edwards Lifesciences Corporation

$51.82B

 DXCM

DexCom, Inc.

$33.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Hyperfine, Inc.

Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system. It serves intensive care units, neurology offices, emergency departments, and comprehensive and primary stroke accredited facilities through direct sales and distributors in the United States, Canada, the United Kingdom, other European and Middle Eastern markets, Australia, and New Zealand. The company was founded in 2014 and is based in Guilford, Connecticut.

Visit website →